Soeda, Keisuke
Komaba, Hirotaka http://orcid.org/0000-0002-1704-4507
Nakagawa, Yosuke
Kawabata, Chiaki
Wada, Takehiko
Takahashi, Hiroo
Takahashi, Yuichiro
Hyodo, Toru
Hida, Miho
Suga, Takao
Kakuta, Takatoshi
Fukagawa, Masafumi
Funding for this research was provided by:
Salt Science Research Foundation (No. 2128)
Japan Society for the Promotion of Science (JP23790958, JP25461257)
Article History
Received: 27 September 2023
Accepted: 15 January 2024
First Online: 21 March 2024
Declarations
:
: HK has received honoraria, consulting fees, and/or grant support from Chugai Pharmaceutical, Kissei Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical, Sanwa Kagaku Kenkyusho, and Torii Pharmaceutical. YN has received grant support from Bayer Yakuhin. TW has received honoraria, consulting fees, and/or grant support from Astellas Pharma, AstraZeneca, Daiichi Sankyo, Fuso Pharmaceutical, Kissei Pharmaceutical, Kyowa Kirin, Mitsubishi Tanabe Pharma, Novartis, Ono Pharmaceutical, and Otsuka Pharmaceutical. TK has received honoraria and/or consulting fees from Chugai Pharmaceutical, Kissei Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical, Sanwa Kagaku Kenkyusho, and Toray Medical. MF has received honoraria, consulting fees, and/or grant support from Bayer Yakuhin, Chugai Pharmaceutical, Kissei Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical, and Sanwa Kagaku Kenkyusho. The remaining authors have nothing to disclose.
: This study was approved by the Institutional Review Board of Tokai University School of Medicine (No. 11R-061 and No. 15R-220).
: The present study complies with the guidelines for human studies. This study does not contain any studies with animals.
: The institutional review board waived the requirement for written informed consent from participants in the historical cohort study, whereas all participants in the Tokai Dialysis Prospective Cohort Study provided written informed consent.